FINANCIAL INSTRUMENTS |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Financial Instruments Disclosure [Abstract] | |
| Financial Instruments | NOTE F: FINANCIAL INSTRUMENTS The Company’s financial instruments include temporary cash investments, restricted cash, accounts receivable, accounts payable, Trade Receivable Facility borrowings, Revolving Facility borrowings and publicly-registered long-term notes and debentures. The carrying values of temporary cash investments, restricted cash, accounts receivable and accounts payable approximate their fair values. The carrying value and fair value of the Company’s debt were $6.0 billion and $5.4 billion, respectively, at June 30, 2026 and $5.3 billion and $4.9 billion, respectively, at December 31, 2025. Due to their short-term nature, the carrying value of Trade Receivable Facility borrowings approximates their fair value. The estimated fair value of the Company’s publicly-registered long-term debt was estimated based on Level 2 of the fair value hierarchy using observable market data. |